Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Google’s World Cup brand counterattack highlights shifting search behavior
The tech giant is running ads intended to reintroduce its search engine to users, as it begins to feel competitive heat in the AI era.
The hunt for a post-LiveRamp successor is already underway
Prospects are less interested in replicating LiveRamp than securing identity, data and infrastructure.
Cannes Briefing: Creators didn’t come to Cannes for parties this year. They came for briefs.
At a festival where one company’s absence from a patch of sand can be read a dozen different ways, creators are giving Cannes Lions a different kind of energy.